Jane Huang

Insider Reports History

Entity
Individual
Location
C/O Mourant Ozannes Corporate Services, 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane Huang:

Insider Reports Filed by Jane Huang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRLD Prelude Therapeutics Inc Feb 4, 2025 1 $0 4 Feb 5, 2025 President, CMO
PRLD Prelude Therapeutics Inc Jan 4, 2025 3 -$5.36K 4 Jan 7, 2025 President, CMO
PRLD Prelude Therapeutics Inc Oct 4, 2024 3 -$6.7K 4 Oct 7, 2024 President, CMO
PRLD Prelude Therapeutics Inc Jul 4, 2024 3 -$12K 4 Jul 8, 2024 President, CMO
TARA Protara Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
PRLD Prelude Therapeutics Inc Apr 4, 2024 3 -$15.9K 4 Apr 8, 2024 President, CMO
PRLD Prelude Therapeutics Inc Mar 1, 2024 1 $0 4 Mar 4, 2024 President, CMO
PRLD Prelude Therapeutics Inc Jan 4, 2024 3 -$14.5K 4 Jan 8, 2024 President, CMO
PRLD Prelude Therapeutics Inc Oct 4, 2023 2 $0 4 Oct 6, 2023 President, CMO
PRLD Prelude Therapeutics Inc Jul 4, 2023 3 -$15.1K 4 Jul 6, 2023 President, CMO
TARA Protara Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
PRLD Prelude Therapeutics Inc Apr 4, 2023 3 -$81.3K 4 Apr 6, 2023 President, CMO
PRLD Prelude Therapeutics Inc Feb 7, 2023 1 $0 4 Feb 9, 2023 President, CMO
TARA Protara Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
PRLD Prelude Therapeutics Inc May 2, 2022 2 $0 4 May 4, 2022 President, CMO
PRLD Prelude Therapeutics Inc Apr 4, 2022 0 $0 3 Apr 6, 2022 President, CMO
BGNE BeiGene, Ltd. Dec 14, 2021 8 -$237K 4 Dec 16, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Nov 30, 2021 4 -$377K 4 Dec 2, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Nov 17, 2021 11 -$392K 4 Nov 19, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Oct 19, 2021 9 -$379K 4 Oct 21, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Sep 20, 2021 16 -$1.67M 4 Sep 22, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Sep 13, 2021 8 -$4.62M 4 Sep 15, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Aug 31, 2021 6 -$347K 4 Sep 2, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Jul 15, 2021 12 -$3.9M 4 Jul 19, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Jun 28, 2021 9 -$639K 4 Jun 30, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Jun 16, 2021 3 -$153K 4 Jun 21, 2021 CMO, Hematology
TARA Protara Therapeutics, Inc. Jun 9, 2021 2 $0 4 Jun 10, 2021 Director
TARA Protara Therapeutics, Inc. Jun 9, 2021 0 $0 3 Jun 10, 2021 Director
BGNE BeiGene, Ltd. Jun 7, 2021 1 -$212K 4 Jun 9, 2021 CMO, Hematology
BGNE BeiGene, Ltd. May 28, 2021 11 -$686K 4 Jun 2, 2021 CMO, Hematology